Case Report

Late Recurrence of Ovarian Cancer after 18 Years of Disease-Free Survival: A Case Report and Review of the Literature

Table 2

Summary of individual studies.

ReferencesTime to recurrence (years)Age of first treatmentStageInitial treatmentHistological typeRecurrence siteTreatmentDFP (months)

Zylberberg et al. [7] (3 cases)2133IIICTAH+BSO+OM+excision of visible masses→ten cycles of monthly adjuvant chemotherapy (intraperitoneal and intravenously)SerousAppendixAppendectomy, suboptimal cytoreduction, and chemotherapy37
2150ICTAH+BSO+OM, adjuvant chemotherapyLower axilla, hepatic nodules, diffuse peritoneal carcinomatosis, and bone metastasesChemotherapy19
2632IIICComplete cytoreduction, adjuvant chemotherapy, and radiotherapyPara-aortic lymph nodeLaparotomy excision of the mass36

Sahdev et al. [1] (4 cases)Ungiven, include a case of 31 yearsNAI, I, IIIC, and unknownNANAOf 4 cases, 4 pelvic mass, 2 peritoneal, 2 nodal, 2 serosal and mesenteric, 2 ascites, and visceralChemotherapyNA

Testelmans et al. [8]2336NATAH+USO and adjuvant chemotherapySerous papillary ovarian carcinomaThoracic wallCytoreduction of the right posterior dorsal thoracic wall, part of the diaphragm, azygos vein, thoracic duct, sympathetic chain, and mediastinal fat; mediastinal lymph node dissection; and local radiotherapy to the mediastinum and the posterior thoracic wall12

Izuishi et al. [9]2032IICTAH+BSO and adjuvant chemotherapy; a year later, second-look surgery, low anterior resection, and adjuvant chemotherapySerous papillary adenocarcinoma contained components of a poorly differentiated adenocarcinomaSpleenSplenectomy60

Menczer et al. [10]2822IIICTAH+BSO+pOM, adjuvant chemotherapy 1 year after, and “second-look” operationSerousPara-aortic retroperitoneal massComplete cytoreductionNA

Otsuka and Shoji [11]2529IUSO (right) during the first trimester of the pregnancy, spontaneous abortion after surgery, adjuvant chemotherapy, and TAH+USO (left)High-grade endometrioid carcinoma with areas of serous histologyPara-aortic lymph nodePara-aortic lymph node resection, chemotherapy, and radiation107

Inoue et al. [12]2938IIIRadical hysterectomy+OM and adjuvant chemotherapySerousLung, anterior mediastinum, and liverVATS, chemotherapy, and subsequently bevacizumab alone12

Omura et al. [13]3123NABSO; 2 years later, uterine metastasis, extended hysterectomy, and adjuvant chemotherapyLow-grade serousThymic epithelial tumorPartial thymectomy19

Chiba et al. [14]4138ICTAH+BSO+pOM and adjuvant chemotherapyLow-grade serousPancreas and liverChemotherapyNA

Takagi et al. [15]3046NARadical hysterectomy and adjuvant chemotherapyHigh-grade serousSpleen, peritoneal dissemination, para-aortic and Virchow lymph nodes, intestine, and pouch of DouglasPartial resection of the intestine; other not mentionedNA

Current case1857ICTAH+BSO+pOM and adjuvant chemotherapyHigh-grade serousSpleen and liverChemotherapy, hepatic resection (right lobe; segments 5, 6, and 8+splenectomy+cholecystectomy) and adjuvant chemotherapy56

TAH: total abdominal hysterectomy; USO: unilateral salpingo-oophorectomy; BSO: bilateral salpingo-oophorectomy; pOM: partial omentectomy; NA: none applicable.